Characteristic pathological associations in multiple endocrine neoplasia type 1;Associations pathologiques caracteristiques dans la neoplasie endocrinienne multiple de type 1

Presse Medicale

Volumn 25, Issue 27, 1996, Pages 1229-1233

  Chigot, J P ^a   Bendib, S ^a   Turpin, G ^a   Benlian, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL LINE; CHROMOSOME 11; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FAMILY; FEMALE; GENETIC MARKER; HETEROZYGOTE DETECTION; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; TUMOR SUPPRESSOR GENE; AGED; GENETICS; MIDDLE AGED; PEDIGREE; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PEDIGREE; RETROSPECTIVE STUDIES;

EID: 0030596777     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. Familial multiple endocrine neoplasia type 1: a new look at pathophysiology. Endocr Rev 1987 ; 8:391-405.
2. Nakamura Y, Larsson C, Julier C et al. Localization of the genetic defect in multiple endocrine neoplasia type I within a small of chromosome 11. Am J Hum Genet 1989 ; 44:751-5.
3. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988 ; 332:85-7.
4. Larsson C, Calender A, Grimmond S et al. Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J Int Med 1995 ; 5:33-8.
5. Cougard P, Proye C. Registre national des néoplasies endocriniennes multiples de type I. Résultats préliminaires de l'enquête de l'association française de chirurgie endocrinienne. Rev Fr Endocrinol Clin 1991 ; 32:219-27.
6. Andersen ØH, Jørgensen PE, Bardram L, Histed L. Screening for multiple endocrine neoplasia type 1 in patients with recognized pituitary adenoma. Clin Endocrinol 1990 ; 33:771-5.
7. Sert C, Champigneulles A, Franc B et al. Association inhabituelle d'un cancer thyroïdien sécrétant de la somatostatine et d'une tumeur duodénale sécrétant de la calcitonine. Ann Endocrinol (Paris) 1993 ; 54:175-9.
8. Carreau A, Badet C, Laville M et al. Néoplasie endocrinienne multiple de type I. Hormones digestives dans le dépistage. Presse Med 1993 ; 22:1811-14.
9. Skogseid B, Eriksson B, Lundqvist G et al. Multiple endocrine neoplasia type I: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991 ; 73:281-7.
10. Brandi ML, Aurbach GD, Fitzpatrick LA et al. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 1986 ; 314:1287-93.
11. Benya RV, Metz DC, Venzon DJ et al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients wich multiple endocrine neoplasia type 1. Am J med 1994 ; 97:436-44.
12. Skogseid B, Öberg K, Benson L et al. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab 1987 ; 64:1233-40.
13. Skogseid B, Larsson C, Lindgren PG et al. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1992 ; 75:76-81.